Wuhan Hiteck Biological Pharma Co.,Ltd (SZSE:300683) agreed to acquire 26.995% stake in Beijing Shadong Biotechnology Co., Ltd. from JunHe Enterprise Management Co., Ltd., Yang Shifang, Cui Junsheng, Sha Bingdong and Guo Cheng on December 8, 2023. The has been reviewed and approved by the sixth meeting of the fifth board of directors and the second extraordinary general meeting of shareholders in 2014 of Wuhan Hiteck Biological Pharma Co.,Ltd (SZSE:300683).

Wuhan Hiteck Biological Pharma Co.,Ltd (SZSE:300683) completed the acquisition of a 6.995% stake in Beijing Shadong Biotechnology Co., Ltd. from JunHe Enterprise Management Co., Ltd., Yang Shifang, Cui Junsheng, Sha Bingdong and Guo Cheng on February 20, 2024.